News

In its update, GSK reported a 17% rise in speciality medicines across its HIV, cancer and respiratory business to £2.93 ...
AZ has already thrown down a marker for its tougher stance on Europe with an earlier decision to abandon a $560 million vaccine manufacturing plant initially intended for the UK, sparking speculation ...
Abeona Therapeutics' Zevaskyn, a cell therapy based on engineered keratinocytes harvested from patients, has been approved in ...
Novo Nordisk has sought strength in numbers in the battle for telehealth obesity drug sales in the US, enlisting the aid of ...
For some patients, specialist pre-referral advice would let them start treatment in primary care quicker and in turn reduce the pressures on waiting lists. NHS Wales is using technology that allows ...
Grambley discusses how AI can be leveraged to create highly personalised patient engagement strategies, tailored to ...
According to the sponsors, the bill would "eliminate the tax deduction companies can claim for pharmaceutical marketing and ...